GABAergic control of depression-related brain states

Bernhard Luscher, Thomas Fuchs

Research output: Chapter in Book/Report/Conference proceedingChapter

34 Citations (Scopus)

Abstract

The GABAergic deficit hypothesis of major depressive disorders (MDDs) posits that reduced γ-aminobutyric acid (GABA) concentration in brain, impaired function of GABAergic interneurons, altered expression and function of GABAA receptors, and changes in GABAergic transmission dictated by altered chloride homeostasis can contribute to the etiology of MDD. Conversely, the hypothesis posits that the efficacy of currently used antidepressants is determined by their ability to enhance GABAergic neurotransmission. We here provide an update for corresponding evidence from studies of patients and preclinical animal models of depression. In addition, we propose an explanation for the continued lack of genetic evidence that explains the considerable heritability of MDD. Lastly, we discuss how alterations in GABAergic transmission are integral to other hypotheses of MDD that emphasize (i) the role of monoaminergic deficits, (ii) stress-based etiologies, (iii) neurotrophic deficits, and (iv) the neurotoxic and neural circuit-impairing consequences of chronic excesses of glutamate. We propose that altered GABAergic transmission serves as a common denominator of MDD that can account for all these other hypotheses and that plays a causal and common role in diverse mechanistic etiologies of depressive brain states and in the mechanism of action of current antidepressant drug therapies.

Original languageEnglish (US)
Title of host publicationAdvances in Pharmacology
PublisherAcademic Press Inc.
Pages97-144
Number of pages48
DOIs
StatePublished - Jan 1 2015

Publication series

NameAdvances in Pharmacology
Volume73
ISSN (Print)1054-3589
ISSN (Electronic)1557-8925

Fingerprint

Major Depressive Disorder
Depression
Brain
Antidepressive Agents
Aminobutyrates
Aptitude
Interneurons
GABA-A Receptors
Synaptic Transmission
gamma-Aminobutyric Acid
Chlorides
Glutamic Acid
Homeostasis
Animal Models
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Luscher, B., & Fuchs, T. (2015). GABAergic control of depression-related brain states. In Advances in Pharmacology (pp. 97-144). (Advances in Pharmacology; Vol. 73). Academic Press Inc.. https://doi.org/10.1016/bs.apha.2014.11.003
Luscher, Bernhard ; Fuchs, Thomas. / GABAergic control of depression-related brain states. Advances in Pharmacology. Academic Press Inc., 2015. pp. 97-144 (Advances in Pharmacology).
@inbook{22a0f609923f4717a7b21d7a35427a37,
title = "GABAergic control of depression-related brain states",
abstract = "The GABAergic deficit hypothesis of major depressive disorders (MDDs) posits that reduced γ-aminobutyric acid (GABA) concentration in brain, impaired function of GABAergic interneurons, altered expression and function of GABAA receptors, and changes in GABAergic transmission dictated by altered chloride homeostasis can contribute to the etiology of MDD. Conversely, the hypothesis posits that the efficacy of currently used antidepressants is determined by their ability to enhance GABAergic neurotransmission. We here provide an update for corresponding evidence from studies of patients and preclinical animal models of depression. In addition, we propose an explanation for the continued lack of genetic evidence that explains the considerable heritability of MDD. Lastly, we discuss how alterations in GABAergic transmission are integral to other hypotheses of MDD that emphasize (i) the role of monoaminergic deficits, (ii) stress-based etiologies, (iii) neurotrophic deficits, and (iv) the neurotoxic and neural circuit-impairing consequences of chronic excesses of glutamate. We propose that altered GABAergic transmission serves as a common denominator of MDD that can account for all these other hypotheses and that plays a causal and common role in diverse mechanistic etiologies of depressive brain states and in the mechanism of action of current antidepressant drug therapies.",
author = "Bernhard Luscher and Thomas Fuchs",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/bs.apha.2014.11.003",
language = "English (US)",
series = "Advances in Pharmacology",
publisher = "Academic Press Inc.",
pages = "97--144",
booktitle = "Advances in Pharmacology",
address = "United States",

}

Luscher, B & Fuchs, T 2015, GABAergic control of depression-related brain states. in Advances in Pharmacology. Advances in Pharmacology, vol. 73, Academic Press Inc., pp. 97-144. https://doi.org/10.1016/bs.apha.2014.11.003

GABAergic control of depression-related brain states. / Luscher, Bernhard; Fuchs, Thomas.

Advances in Pharmacology. Academic Press Inc., 2015. p. 97-144 (Advances in Pharmacology; Vol. 73).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - GABAergic control of depression-related brain states

AU - Luscher, Bernhard

AU - Fuchs, Thomas

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The GABAergic deficit hypothesis of major depressive disorders (MDDs) posits that reduced γ-aminobutyric acid (GABA) concentration in brain, impaired function of GABAergic interneurons, altered expression and function of GABAA receptors, and changes in GABAergic transmission dictated by altered chloride homeostasis can contribute to the etiology of MDD. Conversely, the hypothesis posits that the efficacy of currently used antidepressants is determined by their ability to enhance GABAergic neurotransmission. We here provide an update for corresponding evidence from studies of patients and preclinical animal models of depression. In addition, we propose an explanation for the continued lack of genetic evidence that explains the considerable heritability of MDD. Lastly, we discuss how alterations in GABAergic transmission are integral to other hypotheses of MDD that emphasize (i) the role of monoaminergic deficits, (ii) stress-based etiologies, (iii) neurotrophic deficits, and (iv) the neurotoxic and neural circuit-impairing consequences of chronic excesses of glutamate. We propose that altered GABAergic transmission serves as a common denominator of MDD that can account for all these other hypotheses and that plays a causal and common role in diverse mechanistic etiologies of depressive brain states and in the mechanism of action of current antidepressant drug therapies.

AB - The GABAergic deficit hypothesis of major depressive disorders (MDDs) posits that reduced γ-aminobutyric acid (GABA) concentration in brain, impaired function of GABAergic interneurons, altered expression and function of GABAA receptors, and changes in GABAergic transmission dictated by altered chloride homeostasis can contribute to the etiology of MDD. Conversely, the hypothesis posits that the efficacy of currently used antidepressants is determined by their ability to enhance GABAergic neurotransmission. We here provide an update for corresponding evidence from studies of patients and preclinical animal models of depression. In addition, we propose an explanation for the continued lack of genetic evidence that explains the considerable heritability of MDD. Lastly, we discuss how alterations in GABAergic transmission are integral to other hypotheses of MDD that emphasize (i) the role of monoaminergic deficits, (ii) stress-based etiologies, (iii) neurotrophic deficits, and (iv) the neurotoxic and neural circuit-impairing consequences of chronic excesses of glutamate. We propose that altered GABAergic transmission serves as a common denominator of MDD that can account for all these other hypotheses and that plays a causal and common role in diverse mechanistic etiologies of depressive brain states and in the mechanism of action of current antidepressant drug therapies.

UR - http://www.scopus.com/inward/record.url?scp=84921691547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921691547&partnerID=8YFLogxK

U2 - 10.1016/bs.apha.2014.11.003

DO - 10.1016/bs.apha.2014.11.003

M3 - Chapter

C2 - 25637439

AN - SCOPUS:84921691547

T3 - Advances in Pharmacology

SP - 97

EP - 144

BT - Advances in Pharmacology

PB - Academic Press Inc.

ER -

Luscher B, Fuchs T. GABAergic control of depression-related brain states. In Advances in Pharmacology. Academic Press Inc. 2015. p. 97-144. (Advances in Pharmacology). https://doi.org/10.1016/bs.apha.2014.11.003